Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.
<p><strong>Objectives:</strong> Recruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment decisions. These were explored in the Prostate cancer testing and Treatment (ProtecT) study.</p> <...
Auteurs principaux: | Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Elsevier
2019
|
Documents similaires
-
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
par: Donovan, JL, et autres
Publié: (2017) -
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
par: J. Donovan, et autres
Publié: (2003-01-01) -
Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
par: Young, GJ, et autres
Publié: (2017) -
Addressing patient treatment preferences at trial recruitment.
par: Mills, N, et autres
Publié: (2011) -
Exploring treatment preferences facilitated recruitment to randomized controlled trials
par: Mills, N, et autres
Publié: (2011)